Fulvestrant

Results: 22



#Item
11Approved by the Vice-Chairperson – October 27, 2010 VOLUNTARY COMPLIANCE UNDERTAKING OF ASTRAZENECA CANADA INC. TO THE PATENTED MEDICINE PRICES REVIEW BOARD

Approved by the Vice-Chairperson – October 27, 2010 VOLUNTARY COMPLIANCE UNDERTAKING OF ASTRAZENECA CANADA INC. TO THE PATENTED MEDICINE PRICES REVIEW BOARD

Add to Reading List

Source URL: www.pmprb-cepmb.gc.ca

Language: English - Date: 2013-01-18 14:33:28
12Microsoft Word - Annex A[removed]docx

Microsoft Word - Annex A[removed]docx

Add to Reading List

Source URL: www.nsfsport.com

Language: English - Date: 2010-12-14 03:50:46
13Official March 1, 2012  Errata 1 ERRATA Following is a list of errata and corrections to USP–NF. The page number indicates where the item is found and in which

Official March 1, 2012 Errata 1 ERRATA Following is a list of errata and corrections to USP–NF. The page number indicates where the item is found and in which

Add to Reading List

Source URL: www.usp.org

Language: English - Date: 2012-02-24 15:58:42
14FASLODEX (fulvestrant) injection Label

FASLODEX (fulvestrant) injection Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-11-15 15:20:52
1521344 Fulvestrant Clinpharm PREA

21344 Fulvestrant Clinpharm PREA

Add to Reading List

Source URL: www.fda.gov

Language: English
1621344 Fulvestrant Statistical PREA

21344 Fulvestrant Statistical PREA

Add to Reading List

Source URL: www.fda.gov

Language: English
1721344 Fulvestrant CTDLClinical PREA

21344 Fulvestrant CTDLClinical PREA

Add to Reading List

Source URL: www.fda.gov

Language: English
18Pediatric Postmarket Pharmacovigilance and Drug Utilization Review

Pediatric Postmarket Pharmacovigilance and Drug Utilization Review

Add to Reading List

Source URL: www.fda.gov

Language: English
19HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FASLODEX® safely and effectively. See full prescribing information for FASLODEX. FASLODEX® (fulvestrant) injection

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FASLODEX® safely and effectively. See full prescribing information for FASLODEX. FASLODEX® (fulvestrant) injection

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-07-16 13:44:23
20

PDF Document

Add to Reading List

Source URL: www.epo.org

Language: English - Date: 2013-06-06 17:04:05